15 papers
Rheumatology focuses on understanding and treating conditions that cause pain, swelling, and stiffness in the joints, muscles, and connective tissues. From common issues like arthritis to complex autoimmune disorders, this vital field seeks to improve quality of life for millions of people living with chronic inflammation. Because medical research moves fast, staying updated with the latest discoveries can be challenging without a clear guide.
At Gist.Science, we process every new preprint in this category as it appears on medRxiv, ensuring you never miss a breakthrough. We transform these raw studies into both plain-language overviews and detailed technical summaries, making complex findings accessible to everyone regardless of their background. Below are the latest papers in rheumatology that have been recently analyzed and summarized for you.
This study identifies a novel inborn error of immunity caused by human GPR174 deficiency, which disrupts lysophosphatidylserine-mediated suppression of T cell proliferation and cytokine production, leading to polyclonal lymphoproliferation, autoimmunity, and necrotizing lymphadenitis.
The authors developed an open-source, interactive Shiny platform to make the Lupus Mexican Registry data more accessible, thereby empowering community-oriented research and improving the visibility of underrepresented populations in lupus studies.
This study combines bibliometric mapping and structured content analysis of research from 2016 to 2025 to reveal that while exercise interventions for rheumatoid arthritis are increasingly focused on patient-centered outcomes, the evidence base remains imbalanced with robust data for aerobic and resistance training but limited depth for emerging modalities like mind-body and high-intensity interval training.
This longitudinal study of over 2,000 systemic sclerosis patients reveals that itch is a common and moderately severe symptom that remains stable in both prevalence and intensity regardless of disease onset age or duration, challenging the previous belief that itch is most significant only in early disease.
A six-month pilot study at the Colorado Arthritis Center demonstrates that the cliexa-RA digital platform significantly enhances rheumatoid arthritis management by reducing patient intake and clinician documentation times by 52% and 77% respectively, while simultaneously improving patient satisfaction, workflow efficiency, and administrative cost-effectiveness within the Quadruple Aim framework.
This study identifies that type-1 interferon-driven activation of specific immune cells precedes subclinical joint inflammation in individuals at imminent risk of rheumatoid arthritis, while a shift toward tissue-directed inflammatory and cytotoxic programs occurs concurrently with the onset of detectable synovitis.
This study demonstrates that transcriptome-wide Mendelian randomization results from large-scale population data significantly correlate with causal inferences derived from deep learning and double machine learning on single-cell transcriptomes, thereby validating a cross-scale convergence of statistical and systems biology that bridges the translational gap in understanding complex diseases like rheumatoid arthritis.
This retrospective cohort study demonstrates that combining Iguratimod with Yunke injection is a safe and effective alternative treatment for Ankylosing Spondylitis patients with contraindications to biologics or JAK inhibitors, offering superior disease activity improvement and reduced NSAID dependency compared to Iguratimod monotherapy without increasing adverse reactions.
This study of 59,475 UK Biobank participants reveals that radiographic hip and knee osteoarthritis exhibit distinct patterns of inter-joint relationships, symptom associations, and risk factor profiles, highlighting the heterogeneity of the disease and the need for joint-specific treatment approaches.
This study establishes autoantibody internalization as a shared pathogenic mechanism across diverse autoimmune diseases by demonstrating that patient-derived antibodies enter cells, induce specific transcriptomic signatures and inflammatory responses in multiple cell types, and drive tissue damage through a unified framework.